Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy Virtual 2020 | Key game-changers in multiple myeloma

Kenneth Anderson, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the most exciting developments in the treatment of multiple myeloma (MM). Specifically, targeted therapies and immunotherapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).